Text Size

Comparison of Coronary CT Angiography to Invasive Coronary Angiography

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2005 by Hadassah Medical Organization.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00146887
First received: September 4, 2005
Last updated: November 6, 2006
Last verified: August 2005
History of Changes
  Purpose

The purpose of the trial is to investigate the accuracy of coronary CT compared to the conventional "gold standard" cardiac catheterization.


Condition Intervention
Atherosclerosis, Coronary
 Procedure: coronary catheterization

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: A Trial Comparing the Sensitivity and Specificity of Coronary Angiography With Coronary CT Angiography

Resource links provided by NLM:

MedlinePlus related topics: Atherosclerosis
U.S. FDA Resources

Further study details as provided by Hadassah Medical Organization:

Primary Outcome Measures:
  • CT sensitivity and specificity

Estimated Enrollment: 40
Study Start Date: January 2005
Estimated Study Completion Date: August 2005
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

40 Patients who are scheduled to undergo coronary angiogram will be recruited at Mount Scopus and Ein Kerem

Exclusion Criteria:

  1. CABG or stent implantation in the past.
  2. Atrial fibrillation

  3. Contraindication for beta blockers

    1. Obstructive pulmonary disease
    2. Severe peripheral vascular disease
    3. Sick sinus syndrome or AV block greater than 1st degree.
    4. Systolic blood pressure below 100 mm Hg.
  4. Renal disease or other conditions that might increase the risk of contrast nephropathy (diabetes mellitus, SLE, paraproteinemia, malignancy, liver disease)
  5. Allergy to contrast material.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00146887

Contacts
Contact: Ronen Durst, MD 972-2-6777111 durst@cc.huji.ac.il

Locations
Israel
Hadassah Medical Center Recruiting
Jerusalem, Israel
Contact: Ronen Durst, MD     972-2-50-7874548     durst@cc.huji.ac.il    
Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Principal Investigator: ronen durst, MD Hadassah Medical Organization
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00146887     History of Changes
Other Study ID Numbers: 21-03.09.04-HMO-CTIL, Non applicable
Study First Received: September 4, 2005
Last Updated: November 6, 2006
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Hadassah Medical Organization:
Coronary CT
sensitivity
specificity

Additional relevant MeSH terms:
Atherosclerosis
Coronary Artery Disease
Myocardial Ischemia
Arteriosclerosis
Arterial Occlusive Diseases
 Vascular Diseases
Cardiovascular Diseases
Coronary Disease
Heart Diseases

ClinicalTrials.gov processed this record on May 16, 2013